Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Biotechnical development of genetic addiction risk score (GARS) and selective evidence for inclusion of polymorphic allelic risk in substance use disorder (SUD).
Journal: Journal of systems and integrative neuroscience
Published: February 22, 2021
Molecular neuro-biological and systemic health benefits of achieving dopamine homeostasis in the face of a catastrophic pandemic (COVID- 19): A mechanistic exploration.
Journal: Journal of systems and integrative neuroscience
Published: September 16, 2020
In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing.
Journal: Current psychopharmacology
Published: May 21, 2020
Addiction by Any Other Name is Still Addiction: Embracing Molecular Neurogenetic/Epigenetic Basis of Reward Deficiency.
Journal: Journal of addiction science
Published: May 21, 2020
Americas' opioid/psychostimulant epidemic would benefit from general population early identification of genetic addiction risk especially in children of alcoholics (COAs).
Journal: Journal of systems and integrative neuroscience
Published: February 22, 2020
Death by Opioids: Are there non-addictive scientific solutions?
Journal: Journal of systems and integrative neuroscience
Published: December 12, 2019
The benefits of genetic addiction risk score (GARS™) and pro-dopamine regulation in combating suicide in the American Indian population.
Journal: Journal of systems and integrative neuroscience
Published: October 30, 2019
Genetic Addiction Risk Score (GARS™) as a Predictor of Substance Use Disorder: Identifying Predisposition Not Diagnosis.
Journal: Current trends in medical diagnostic methods
Published: July 06, 2019
Hypodopaminergia and "Precision Behavioral Management" (PBM): It is a Generational Family Affair.
Journal: Current pharmaceutical biotechnology
Published: May 28, 2019
Introducing "Precision Addiction Management (PAM®)" as an Adjunctive Genetic Guided Therapy for Abusable Drugs in America.
Journal: Open access journal of behavioural science & psychology
Published: January 22, 2019
Can We Combat Reward Deficiency Behaviors (RDS) including Substance Use Disorder (SUD) through Genetic Risk Screening coupled with Precision Pro-Dopamine Regulation by Algorithmic matched Polymorphic Allelic Risks.
Journal: Madridge journal of molecular biology
Published: January 01, 2019
Understanding the Scientific Basis of Post-traumatic Stress Disorder (PTSD): Precision Behavioral Management Overrides Stigmatization.
Journal: Molecular neurobiology
Published: November 25, 2018
Last Updated: 09/26/2026